Silver Book Fact

As the United States population ages, researchers estimate that the prevalence of Alzheimer’s disease will come close to quadrupling over the next 50 years, when 1 in 45 may be living with the disease.

Brookmeyer, Ronald, Sarah M. Gray, and Claudia H. Kawas. Projections of Alzheimer’s Disease in the United States and the Public Health Impact of Delaying Disease Onset. Am J Public Health. 1998; 88(9): 1337-42. http://www.ajph.org/cgi/content/abstract/88/9/1337?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=brookmeyer&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT

Reference

Title
Projections of Alzheimer’s Disease in the United States and the Public Health Impact of Delaying Disease Onset
Publication
Am J Public Health
Publication Date
1998
Authors
Brookmeyer, Ronald, Sarah M. Gray, and Claudia H. Kawas
Volume & Issue
Volume 88, Issue 9
Pages
1337-42
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Human Burden

Related Facts

  • Lifetime risk of Alzheimer’s
     
  • Symptoms of Parkinson’s Disease Psychosis in Half of Parkinson’s Disease Patients
     
  • Drug therapy for Parkinson’s disease costs more than $6 billion a year. Costs such as rehabilitation and home care can run as high as $150,000 per patient, per year.  
  • Dementia is correlated with a significantly higher out-of-pocket expenditure for medical care compared with those who have normal cognitive function. In 1995, the annual out-of-pocket expenditure was $1,350 for Americans…  
  • In 2005, the total annual direct and indirect costs to the nation for Parkinson’s disease was projected to be at least $23 billion.